type-2-diabetes

Documents about type-2-diabetes

• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise#18547ClinicalTrials.gov
• Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes#18553ClinicalTrials.gov
• A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus#18555ClinicalTrials.gov
• How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics#18566ClinicalTrials.gov
• High Protein Breakfast on Appetite, Postprandial Glycemia and Weight Loss in T2D#18795ClinicalTrials.gov
• Brain Clock and Insulin Resistance#18798ClinicalTrials.gov
• Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease#28470ClinicalTrials.gov
• A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients#28503ClinicalTrials.gov
• Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes#28510ClinicalTrials.gov
• SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2#28522ClinicalTrials.gov
• Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)#28529ClinicalTrials.gov
• Multi-centre Peer Support Program in Type 2 Diabetes Patients in Hong Kong#28534ClinicalTrials.gov
• A Safety Study of ARRY-403 in Patients With Type 2 Diabetes#28548ClinicalTrials.gov
• Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics#28556ClinicalTrials.gov
• Multiple-dose Tolerability and Pharmacokinetic of IBI362 in Chinese Patients With T2DM#28594ClinicalTrials.gov
• Nurse Telephone Management of Cholesterol in Diabetes#67770ClinicalTrials.gov
• The OBSTACLE Hypoglycemia Study (MK-0000-158)#67777ClinicalTrials.gov
• Dietary Reduction of AGEs to Prevent Cognitive Decline in Elderly Diabetics#67782ClinicalTrials.gov
• Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control#67784ClinicalTrials.gov
• A Study of TG103 in Subjects With Type 2 Diabetes#67792ClinicalTrials.gov
• To Evaluate the Response to Glucagon During Hypoglycemia#67816ClinicalTrials.gov
• Comparison of Glucovance to Insulin for Diabetes During Pregnancy#67832ClinicalTrials.gov
• A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor#67840ClinicalTrials.gov
• WelChol® With Metformin in Treating Patients With Type 2 Diabetes#67853ClinicalTrials.gov
• Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes Melitus#121230ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes#121237ClinicalTrials.gov
• A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)#121284ClinicalTrials.gov
• Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin#121302ClinicalTrials.gov
• Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride#121310ClinicalTrials.gov
• Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes#121318ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)#121320ClinicalTrials.gov
• Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy#121503ClinicalTrials.gov
• Levemir-Body Composition and Energy Metabolism#123424ClinicalTrials.gov
• Mechanism of SGLT2 Inhibition in the Kidney#123625ClinicalTrials.gov
• Evaluating a Type 2 Diabetes Prevention Program#123626ClinicalTrials.gov
• Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia#123629ClinicalTrials.gov
• Sleep Disordered Breathing and Diabetes#329447ClinicalTrials.gov
• A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects#329455ClinicalTrials.gov
• Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes#329456ClinicalTrials.gov
• Prognostic Impact of Diabetes and Weight Variability in Telemonitored Heart Failure#329461ClinicalTrials.gov
• The Effect and Mechanism of MMP-9 in Inducing Atherosclerosis#329476ClinicalTrials.gov
• Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake#329477ClinicalTrials.gov
• Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine#329489ClinicalTrials.gov
• The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients#329500ClinicalTrials.gov
• TARDIS - Photo Elicitation and Intervention#332675ClinicalTrials.gov
• The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes#332704ClinicalTrials.gov
• -Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.#332705ClinicalTrials.gov
• Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food#332710ClinicalTrials.gov
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor#332712ClinicalTrials.gov
• A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin#332715ClinicalTrials.gov

Related topics